CCCC – c4 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
C4 Therapeutics (NASDAQ:CCCC) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Pipeline Momentum Drives C4 Therapeutics Despite Q3 EPS Miss [Seeking Alpha]
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
C4 Therapeutics files $400M mixed shelf offering [Seeking Alpha]
Form S-3 C4 Therapeutics, Inc.
Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Form 10-Q C4 Therapeutics, Inc. For: Sep 30
Form 8-K C4 Therapeutics, Inc. For: Nov 06
Form 4 C4 Therapeutics, Inc. For: Oct 28 Filed by: Mahaney Paige
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.